http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017020971-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee629cf6ed8ce1f50bbc861575a81456
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4222
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26
filingDate 2016-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_235da0bdc7cb24331c554d7ab978ffc7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a7e1165c04a4fcbb7d1d89f02b7ab9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce78cfd32699518a54d81a11c89e4e8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04ccc92d170220dc64db4ab358324af4
publicationDate 2017-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2017020971-A1
titleOfInvention Treatment of short bowel syndrome patients with colon-in-continuity
abstract Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
priorityDate 2004-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9739091-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9803547-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9739031-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5789379-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9545434-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004035624-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9852600-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0149314-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6184201-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9060992-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7411039-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004085471-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02066511-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1231219-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7847061-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6077949-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9943361-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9639031-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6400441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3955
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57181882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408603

Total number of triples: 49.